Impending relapse of myelodysplastic syndrome after allogeneic transplant is difficult to diagnose and requires a multi-modal approach

BACKGROUND: The only potentially curative therapy for myelodysplastic syndrome is allogeneic hematopoietic cell transplant; unfortunately, there is a high relapse rate. The objective of this study was to perform a detailed clinicopathologic study of patients with relapsed myeloid neoplasm following...

Descripción completa

Detalles Bibliográficos
Autores principales: Courville, Elizabeth L., Griffith, Megan, Ustun, Celalettin, Yohe, Sophia, Warlick, Erica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746015/
https://www.ncbi.nlm.nih.gov/pubmed/29299024
http://dx.doi.org/10.1186/s12907-017-0066-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746015/
https://www.ncbi.nlm.nih.gov/pubmed/29299024
http://dx.doi.org/10.1186/s12907-017-0066-8

Ejemplares similares